General Medicine raises $120M to build a nationwide healthcare store
What's the deal? General Medicine, a nationwide healthcare store, has raised $120 million in Series B financing led by Andreessen Horowitz (a16z). Matrix, VXI CapitalDealroom has a profile for this one. Try Dealroom →, Eli Lilly and CompanyDealroom has a profile for this one. Try Dealroom →, Mercy HealthDealroom has a profile for this one. Try Dealroom → through Granger ManagementDealroom has a profile for this one. Try Dealroom →, and BoxGroup also participated. The round brings total funding to $152 million.
What's the endgame? The San Francisco company lets customers search, compare, and buy care, seeing upfront what it costs with and without insurance. Its catalogue spans more than 2,900 products and services across medications, labs, telehealth, specialist e-consults, and select in-person visits and procedures. The new funding will expand the store into more categories of care.
Why now? Founded in 2023 and launched nationwide in May 2025, General Medicine says hundreds of thousands of customers have signed up. It reports that 83% say the company helped them address a health need they had put off; a third had delayed care for more than six months.
What's the pitch? "Everyone's building a healthcare AI agent that can tell you what you might need. What's missing is the infrastructure that lets you actually get it," said chief executive officer TJ Parker. Customers can buy care directly, talk with a licensed clinician — usually the same day — or use an AI chat to explore options. A clinician determines what is clinically appropriate when review is required.
The investor: Vineeta Agarwala, MD, PhD, general partner at a16z, led the investment. The firm's involvement puts a prominent backer behind a model that organises care around customer needs rather than medical specialties. "Consumers don't shop by specialty. They shop by need," said chief product officer Ashwin Muralidharan.
The signal: The round sits near the top of US health Series B deals, in roughly the 95th percentile of more than 3,700 comparable rounds. That underscores investor appetite for consumer-facing healthcare infrastructure as AI makes medical advice abundant but acting on it still difficult.
Read more: prnewswire.com
Image credit: Generated with Gemini
